The FDA approved dihydroergotamine (DHE) nasal powder (Atzumi) 5.2 mg to treat acute migraine with or without aura in adults, Satsuma Pharmaceuticals announced Wednesday. The product is the only ...

The recommended dose of Atzumi is 5.2mg, the contents of 1 nasal device, administered into 1 nostril. The Food and Drug Administration (FDA) has approved Atzumi ™ (dihydroergotamine) nasal ...

Atzumi™ (dihydroergotamine(DHE)) nasal powder is the first and only DHE nasal powder for the acute treatment of migraine with or without aura in adults in an easy-to-use, easy-to-carry device.

Getty Archaeologists have discovered evidence of psychedelic drug use and “snuff tubes" in a formally ... of them specifically contained traces of tobacco and DMT, a drug commonly found in ...

"And I was like, I don't know if that was necessary. I don't think like anyone was close enough to actually see the powder go up our nose." "But I remember giving myself, like, basically a yeast ...

Nasal decongestant sprays are a popular remedy for relieving nasal congestion caused by colds, allergies and sinus infections. These sprays provide quick relief allowing for easier breathing.